Dow Jones: Life Sciences M&A

Life Science M&A: Positioning Companies for Successful Exits

Even as a few of health care's biggest firms merge, the market is ripe for acquisitions. Biotechs are bracing for a big year in M&As and Medtronic's acquisition of two VC-backed companies for over $1 billion is fueling interest in other device M&As.

Find out what you should be doing to prepare your companies for an acquisition and to ensure you get the best deal when the time comes when VentureWire Lifescience and Dow Jones Webinars convene an expert panel for a 90-minute interactive webinar.

Sign up online or by calling 800-775-7654 to register for:
Life Science M&A: Positioning Companies for Successful Exits
Thursday, April 2, 2009 | Noon to 1:30 PM ET
Early Registration: $350. Save $50 when you register by March 30.

Can't make the seminar? Just order the recording.

Speakers:

• Dr. Ross Jaffe, Managing Director, Versant Ventures, a backer of two recently acquired device companies, Ablation Frontiers (Medtronic) and St. Francis Medical Technologies (Kyphon). At Versant, he specializes in early-stage medical device investment. Previously, he was with Brentwood Venture Capital and led investments in medical devices, drug delivery, and health care information systems companies.
• Casey McGlynn, Partner, Wilson Sonsini Goodrich & Rosati where his practice focuses on the organization, funding, and corporate representation of information technology, life sciences and telecommunications companies. He has extensive experience structuring and negotiating M&As, licensing arrangements, and strategic corporate alliances.
• Dan Lepanto, Managing Director, Mergers & Acquisitions, Leerink Swann an investment bank focused exclusively on health care.
• Jennifer Jarrett, Managing Director, Credit Suisse's investment banking division where she leads the coverage of biotechnology companies in the U.S. Her recent M&A experience includes Cerexa's sale to Forest Labs, Chiron's sale to Novartis, NovaCardia's sale to Merck and Peninsula Pharmaceuticals' sale to Johnson & Johnson.
• Dave Barry, Managing Editor, Dow Jones Financial Information Services and the session's moderator.
  

Attend this seminar and walk away with:

• An overview of the current liquidity market
• A look at who's shopping for companies
• A must-follow checklist when picking bankers to manage the sale of your companies
• What attracts corporations to a start-up and how to get their attention
• Keys for working with corporations and leveraging current relationships into sales
• Tips to keep your companies and their intellectual property safe and secure until the deal closes
• Tactics for negotiating the best sale price without turning off possible buyers
• Due diligence: what you should ask a corporation before signing on the dotted line
• Common missteps and pitfalls to watch out for throughout the process
• What to expect after the deal is done
• Corporations are ready to buy and, after investing over $18 billion in the health care companies during the last two years, VCs and entrepreneurs are ready for returns. Make sure you're best prepared for an exit by listening in to Life Science M&A: Positioning Companies for Successful Exits.

Full Event Details:  Click here

TO REGISTER: Sign up online or call 800-775-7654. Remember, when you sign up by March 30, you'll pay only $350.